February 27, 2023: BetaGlue Technologies: the Shareholders’ Meeting renews the BoD, Dr Colin Story appointed CEO
October 19, 2022: BetaGlue Technologies strengthen its expertise in strategic areas with four managers
July 19, 2022: BetaGlue Technologies: closing of a EUR 10 million financing round
July 11, 2022: BetaGlue takes radiotherapy inside solid tumours: first patient treated with BAT-90